S 2817
116th Congress
Senate
Health
Asia
Australia
Canada
Department of Health and Human Services
Europe
Executive agency funding and structure
France
Germany
Health care costs and insurance
Health programs administration and funding
Indian social and development programs
Inflation and prices
Italy
Japan
Medicaid
Medical research
Medicare
Netherlands
North America
End Price Gouging for Insulin Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 7, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6479-6480)
Nov 7, 2019
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
End Price Gouging for Insulin Act
This bill requires the Department of Health and Human Services to set a maximum price for insulin products for individuals and enrollees of federal health programs.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6479-6480)
Related & companion bills
1
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cosponsors
1
Cite this page
U.S. Congress. (2026). S. 2817: End Price Gouging for Insulin Act. 116th Congress. Open America. https://openamerica.io/bill/116-S-2817/
"S. 2817: End Price Gouging for Insulin Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-2817/.
S. 2817, 116th Cong. (2026), https://openamerica.io/bill/116-S-2817/.
[S. 2817: End Price Gouging for Insulin Act](https://openamerica.io/bill/116-S-2817/)